Nidan Laboratories and Healthcare (NSE:NIDAN) Net Margin %: 6.26% (As of Mar. 2025)


NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.60
View Full Analysis

What is Nidan Laboratories and Healthcare Net Margin %?

Nidan Laboratories and Healthcare NSE:NIDAN -3.89% 67 Net Margin % is 6.26% as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

Net margin is calculated as Net Income divided by its Revenue. Nidan Laboratories and Healthcare's Net Income for the six months ended in Mar. 2025 was ₹8.8 Mil. Nidan Laboratories and Healthcare's Revenue for the six months ended in Mar. 2025 was ₹139.9 Mil. Therefore, Nidan Laboratories and Healthcare's net margin for the quarter that ended in Mar. 2025 was 6.26%.

The historical rank and industry rank for Nidan Laboratories and Healthcare's Net Margin % or its related term are showing as below:


NSE:NIDAN's Net Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -2.69
* Ranked among companies with meaningful Net Margin % only.

Nidan Laboratories and Healthcare  (NSE:NIDAN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Nidan Laboratories and Healthcare Net Margin % Related Terms

Nidan Laboratories and Healthcare Net Margin % Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Net Margin % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Margin %
Get a 7-Day Free Trial 11.30 8.98 14.59 -13.37 8.06

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 12.00 16.26 -41.73 10.46 6.26

NSE:NIDAN vs TMO, DHR, IDXX: Net Margin % Comparison

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nidan Laboratories and Healthcare Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's Net Margin % distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's Net Margin % falls into.


NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Nidan Laboratories and Healthcare's Net Margin for the fiscal year that ended in Mar. 2025 is calculated as

Net Margin=Net Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=19.769/245.275
=8.06 %

Nidan Laboratories and Healthcare's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=8.756/139.948
=6.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 6.26% mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Net Margin % of 6.26% as of Mar. 2025. Net margin is the ratio of total net income to net sales. View historical data on Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Net Margin % too high?
Nidan Laboratories and Healthcare's current Net Margin % is 6.26%. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Net Margin % compare to TMO and DHR?
Nidan Laboratories and Healthcare's Net Margin % of 6.26% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Net Margin % is 6.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Net Margin % of 6.26%. The current Net Margin % is 6.26%. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Net Margin % is 6.26% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.60
Price